Medical Marijuana, Inc. and Subsidiary Kannaway® Honored as Stevie® Award Winners in 2019 International Business Awards®

SAN DIEGO, Aug. 20, 2019 — Medical Marijuana, Inc. (OTC:MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the Company was named the winner of a Bronze Stevie® Award in the Most Innovative Company of the Year – Up to 100 Employees category in The 16th Annual International Business Awards.

Also, the Company’s subsidiary Kannaway® received two Stevie® Awards – a Silver Stevie® Award for CEO Blake Schroeder in the Executive of the Year – Health Products & Services category and a Bronze Stevie® Award in the Fastest-Growing Company of the Year – in Canada and the U.S. category.

“Medical Marijuana, Inc. has been devoted to innovating all aspects of the CBD industry since new management took control in March 2011,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “From product innovation and development to laboratory testing, the Company has set many industry standards used to ensure safety and quality and we aim to continue to offer a variety of inventive products and delivery methods for consumers.”

The International Business Awards are the world’s premier business awards program. All individuals and organizations worldwide – public and private, for-profit and non-profit, large and small – are eligible to submit nominations. The 2019 IBAs received entries from organizations in 74 nations and territories.

Stevie® Award winners were determined by the average scores of more than 250 executives worldwide who participated in the judging process from May through early August.

“I am honored to receive this international executive recognition on behalf of Kannaway and am proud of our portfolio of companies for showing the world just how fast we intend to grow,” said Kannaway®CEO Blake Schroeder. “We have accomplished a lot in the past year and our dedicated team has been essential to creating the highest-quality hemp products in the cannabis industry.”

Details about The International Business Awards and the lists of Stevie Award winners are available at

About Medical Marijuana, Inc.

We are a company of firsts®.  Medical Marijuana, Inc. (MJNA) is a cannabis company with three distinct business units in the non-psychoactive cannabinoid space: a global portfolio of cannabinoid-based nutraceutical brands led by Kannaway® and HempMeds®; a pioneer in sourcing the highest-quality legal non-psychoactive cannabis products derived from industrial hemp; and a cannabinoid-based clinical research and botanical drug development sector led by its internal R&D and scientific team and its pharmaceutical investment companies and partners including AXIM®Biotechnologies, Inc. and Kannalife, Inc. Medical Marijuana, Inc. was named a top CBD producer by CNBC. Medical Marijuana, Inc. was also the first company to receive historic import permits for CBD products from the governments of Brazil, Mexico, Argentina, and Paraguay and is a leader in the development of international markets. Medical Marijuana, Inc.’s headquarters is in San Diego, California, and additional information is available at or by visiting

To see Medical Marijuana, Inc.’s corporate video, click here.

Shareholders and consumers are also encouraged to buy CBD oil and other products at Medical Marijuana, Inc.’s shop.


This press release may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of Medical Marijuana, Inc. to be materially different from the statements made herein.


These statements have not been evaluated by the FDA and are not intended to diagnose, treat or cure any disease.


Medical Marijuana, Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). These companies do grow, sell, and distribute hemp-based products and are involved with the federally legal distribution of medical marijuana-based products within certain international markets. Cannabidiol is a natural constituent of hemp oil.


Public Relations Contact:

Andrew Hard

Chief Executive Officer CMW Media

P. 858-264-6600

[email protected]

Investor Relations Contact:

P. (858) 283-4016

[email protected]